Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 13;7(14):3725–3734. doi: 10.1182/bloodadvances.2022009478

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Figure 5. — Overall survival and survival with intervention-free sustained engraftment stratified based on alemtuzumab and CXCL9 levels. Overall survival stratified based on day 0 alemtuzumab levels (A), day +14 CXCL9 levels (C), and day +28 CXCL9 levels (E). Probability of survival with intervention-free sustained engraftment stratified based on day 0 alemtuzumab levels (B), day +14 CXCL9 levels (D), and day +28 CXCL9 levels (F).